SK118498A3 - Novel erythromycin derivatives, method for preparing same, and use thereof as drugs - Google Patents

Novel erythromycin derivatives, method for preparing same, and use thereof as drugs Download PDF

Info

Publication number: SK118498A3
Authority: SK; Slovakia
Prior art keywords: formula; compounds; group; methyl; dideoxy
Prior art date: 1996-02-28

Application number

SK1184-98A

Other languages

English (en)

Slovak (sk)

Inventor

Constantin Agouridas

Jean-Francois Chantot

Original Assignee

Hoechst Marion Roussel Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-02-28

Filing date

1997-02-27

Publication date

1999-07-12

1997-02-27 Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc

1999-07-12 Publication of SK118498A3 publication Critical patent/SK118498A3/sk

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

SK1184-98A 1996-02-28 1997-02-27 Novel erythromycin derivatives, method for preparing same, and use thereof as drugs SK118498A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9602472A FR2745290B1 (fr)	1996-02-28	1996-02-28	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
PCT/FR1997/000351 WO1997031929A1 (fr)	1996-02-28	1997-02-27	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number	Publication Date
SK118498A3 true SK118498A3 (en)	1999-07-12

Family

ID=9489659

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK1184-98A SK118498A3 (en)	1996-02-28	1997-02-27	Novel erythromycin derivatives, method for preparing same, and use thereof as drugs

Country Status (31)

Country	Link
US (1)	US6096714A (es)
EP (1)	EP0885234B1 (es)
JP (1)	JP4102440B2 (es)
KR (1)	KR100486053B1 (es)
CN (1)	CN1168734C (es)
AP (1)	AP952A (es)
AR (1)	AR005999A1 (es)
AT (1)	ATE217633T1 (es)
AU (1)	AU716204B2 (es)
BG (1)	BG63207B1 (es)
BR (1)	BR9707709B1 (es)
CZ (1)	CZ293893B6 (es)
DE (1)	DE69712610T2 (es)
DK (1)	DK0885234T3 (es)
EA (1)	EA001376B1 (es)
EE (1)	EE9800265A (es)
ES (1)	ES2176698T3 (es)
FR (1)	FR2745290B1 (es)
HU (1)	HU227567B1 (es)
IL (1)	IL125622A (es)
NO (1)	NO983955D0 (es)
NZ (1)	NZ331600A (es)
OA (1)	OA10845A (es)
PL (1)	PL191736B1 (es)
PT (1)	PT885234E (es)
SK (1)	SK118498A3 (es)
TR (1)	TR199801713T2 (es)
UA (1)	UA58504C2 (es)
WO (1)	WO1997031929A1 (es)
YU (1)	YU37098A (es)
ZA (1)	ZA971659B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU9649698A (en) *	1997-10-29	1999-05-17	Taisho Pharmaceutical Co., Ltd.	Erythromycin a 11, 12-carbamate derivatives
JP2003527301A (ja) *	1997-10-29	2003-09-16	大正製薬株式会社	エリスロマイシンａ誘導体
FR2780977B1 (fr) *	1998-07-09	2000-09-01	Hoechst Marion Roussel Inc	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
JP4573925B2 (ja) *	1998-07-09	2010-11-04	アベンティス・ファーマ・ソシエテ・アノニム	新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2792637B1 (fr) *	1999-04-26	2001-06-01	Hoechst Marion Roussel Inc	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2781484B1 (fr) *	1998-07-21	2001-08-10	Hoechst Marion Roussel Inc	Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
CZ20012675A3 (cs)	1999-01-27	2002-04-17	Pfizer Products Inc.	Ketolidová antibiotika
CA2373117C (en) *	1999-05-24	2006-02-28	Pfizer Products Inc.	13-methyl-erythromycin derivatives
WO2001010880A1 (fr) *	1999-08-06	2001-02-15	Taisho Pharmaceutical Co., Ltd.	Derives d'erythromycine a
WO2001010878A1 (fr) *	1999-08-06	2001-02-15	Taisho Pharmaceutical Co., Ltd.	Derives d'erythromycine a
AU6316400A (en) *	1999-08-06	2001-03-05	Taisho Pharmaceutical Co., Ltd.	Erythromycin a derivatives
EP1146051A3 (en) *	2000-04-10	2001-10-31	Pfizer Products Inc.	Erythromycin A derivatives
US20020115621A1 (en) *	2000-08-07	2002-08-22	Wei-Gu Su	Macrolide antibiotics
ITMI20021726A1 (it)	2002-08-01	2004-02-02	Zambon Spa	Macrolidi ad attivita' antiinfiammatoria.
EP3738591A3 (en)	2003-03-10	2021-03-24	Merck Sharp & Dohme Corp.	Novel antibacterial agents
WO2005007143A2 (en) *	2003-07-14	2005-01-27	The Board Of Trustees Of The University Of Illinois	Use of makrolides and ketolides for the treatment of tuberculosis
WO2007069264A2 (en) *	2005-12-15	2007-06-21	Alembic Limited	Reference standards for determining the purity of telithromycin and processes therefor
WO2009055557A1 (en) *	2007-10-25	2009-04-30	Cempra Pharmaceuticals, Inc.	Process for the preparation of macrolide antibacterial agents
HRP20160222T1 (hr) *	2008-10-24	2016-04-08	Cempra Pharmaceuticals, Inc.	Biozaštite uporabom makrolida koji sadrže triazol
US9937194B1 (en)	2009-06-12	2018-04-10	Cempra Pharmaceuticals, Inc.	Compounds and methods for treating inflammatory diseases
AU2010292010B2 (en)	2009-09-10	2016-01-07	Cempra Pharmaceuticals, Inc.	Methods for treating malaria, tuberculosis and MAC diseases
NZ602544A (en)	2010-03-22	2014-11-28	Cempra Pharmaceuticals Inc	Crystalline forms of a macrolide, and uses therefor
RU2608390C2 (ru)	2010-05-20	2017-01-18	Семпра Фармасьютикалз, Инк.	Способы получения макролидов и кетолидов, и промежуточных соединений для их получения
JP6042334B2 (ja)	2010-09-10	2016-12-14	センプラファーマシューティカルズ，インコーポレイテッド	疾患治療のための水素結合形成フルオロケトライド
HK1205939A1 (en)	2012-03-27	2015-12-31	Cempra Pharmaceuticals, Inc.	Parenteral formulations for administering macrolide antibiotics
HK1217665A1 (zh)	2013-03-14	2017-01-20	森普拉制药公司	用於治療呼吸道疾病的方法及其製劑
AU2014233240B2 (en)	2013-03-15	2018-08-09	Cempra Pharmaceuticals, Inc.	Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US487411A (en) *		1892-12-06		Island
IL99995A (en) *	1990-11-21	1997-11-20	Roussel Uclaf	Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5444031A (en) *	1993-01-21	1995-08-22	Calgon Carbon Corporation	Process for making catalytic carbon
FR2727969B1 (fr) *	1994-12-09	1997-01-17	Roussel Uclaf	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

1996
- 1996-02-28 FR FR9602472A patent/FR2745290B1/fr not_active Expired - Lifetime
1997
- 1997-02-25 AR ARP970100760A patent/AR005999A1/es unknown
- 1997-02-26 ZA ZA9701659A patent/ZA971659B/xx unknown
- 1997-02-27 WO PCT/FR1997/000351 patent/WO1997031929A1/fr not_active Ceased
- 1997-02-27 NZ NZ331600A patent/NZ331600A/xx unknown
- 1997-02-27 DE DE69712610T patent/DE69712610T2/de not_active Expired - Lifetime
- 1997-02-27 TR TR1998/01713T patent/TR199801713T2/xx unknown
- 1997-02-27 EA EA199800768A patent/EA001376B1/ru not_active IP Right Cessation
- 1997-02-27 JP JP53067197A patent/JP4102440B2/ja not_active Expired - Lifetime
- 1997-02-27 PL PL328608A patent/PL191736B1/pl unknown
- 1997-02-27 KR KR10-1998-0706733A patent/KR100486053B1/ko not_active Expired - Lifetime
- 1997-02-27 DK DK97907141T patent/DK0885234T3/da active
- 1997-02-27 AP APAP/P/1998/001318A patent/AP952A/en active
- 1997-02-27 ES ES97907141T patent/ES2176698T3/es not_active Expired - Lifetime
- 1997-02-27 EP EP97907141A patent/EP0885234B1/fr not_active Expired - Lifetime
- 1997-02-27 UA UA98095031A patent/UA58504C2/uk unknown
- 1997-02-27 PT PT97907141T patent/PT885234E/pt unknown
- 1997-02-27 BR BRPI9707709-7A patent/BR9707709B1/pt not_active IP Right Cessation
- 1997-02-27 IL IL12562297A patent/IL125622A/xx not_active IP Right Cessation
- 1997-02-27 US US09/125,959 patent/US6096714A/en not_active Ceased
- 1997-02-27 HU HU9902576A patent/HU227567B1/hu unknown
- 1997-02-27 AU AU19298/97A patent/AU716204B2/en not_active Expired
- 1997-02-27 CZ CZ19982587A patent/CZ293893B6/cs not_active IP Right Cessation
- 1997-02-27 AT AT97907141T patent/ATE217633T1/de active
- 1997-02-27 EE EE9800265A patent/EE9800265A/xx unknown
- 1997-02-27 SK SK1184-98A patent/SK118498A3/sk unknown
- 1997-02-27 CN CNB971926255A patent/CN1168734C/zh not_active Expired - Lifetime
1998
- 1998-08-12 BG BG102691A patent/BG63207B1/bg unknown
- 1998-08-27 NO NO983955A patent/NO983955D0/no not_active Application Discontinuation
- 1998-08-28 YU YU37098A patent/YU37098A/sh unknown
- 1998-08-28 OA OA9800150A patent/OA10845A/fr unknown

Also Published As

Publication number	Publication date
NO983955L (no)	1998-08-27
CN1168734C (zh)	2004-09-29
HUP9902576A3 (en)	2001-03-28
BR9707709A (pt)	1999-04-06
FR2745290A1 (fr)	1997-08-29
UA58504C2 (uk)	2003-08-15
PL191736B1 (pl)	2006-06-30
JP2000505469A (ja)	2000-05-09
NZ331600A (en)	1999-08-30
BG63207B1 (bg)	2001-06-29
FR2745290B1 (fr)	1998-04-03
EE9800265A (et)	1999-02-15
CZ293893B6 (cs)	2004-08-18
IL125622A0 (en)	1999-04-11
AP9801318A0 (en)	1998-09-30
PT885234E (pt)	2002-10-31
EP0885234B1 (fr)	2002-05-15
NO983955D0 (no)	1998-08-27
PL328608A1 (en)	1999-02-01
EP0885234A1 (fr)	1998-12-23
BR9707709B1 (pt)	2014-10-14
CN1212700A (zh)	1999-03-31
HU227567B1 (en)	2011-08-29
CZ258798A3 (cs)	1998-12-16
AR005999A1 (es)	1999-07-21
ZA971659B (en)	1998-02-26
EA199800768A1 (ru)	1999-02-25
TR199801713T2 (xx)	1998-12-21
JP4102440B2 (ja)	2008-06-18
DK0885234T3 (da)	2002-08-26
KR100486053B1 (ko)	2005-06-16
IL125622A (en)	2003-10-31
DE69712610T2 (de)	2002-11-28
ATE217633T1 (de)	2002-06-15
YU37098A (sh)	1999-07-28
US6096714A (en)	2000-08-01
WO1997031929A1 (fr)	1997-09-04
AU716204B2 (en)	2000-02-24
BG102691A (en)	1999-06-30
DE69712610D1 (de)	2002-06-20
HUP9902576A1 (hu)	1999-12-28
AU1929897A (en)	1997-09-16
EA001376B1 (ru)	2001-02-26
OA10845A (fr)	2003-02-05
AP952A (en)	2001-03-29
KR19990087324A (ko)	1999-12-27
ES2176698T3 (es)	2002-12-01

Publication	Publication Date	Title
SK118498A3 (en)	1999-07-12	Novel erythromycin derivatives, method for preparing same, and use thereof as drugs
JP3130097B2 (ja)	2001-01-31	新規なエリスロマイシン誘導体、その製造法、得られる新規な中間体及びそれらの薬剤としての使用
JP3140703B2 (ja)	2001-03-05	新規なエリスロマイシン、それらの製造法及び薬剤としての用途
KR100371473B1 (ko)	2003-07-22	신규한에리스로마이신유도체,그의제조방법및의약으로서의용도
JPH06199887A (ja)	1994-07-19	新規なエリスロマイシン誘導体、それらの製造法及びそれらの薬剤としての用途
HUP9904392A2 (hu)	2000-05-28	Új eritromicinszármazékok, eljárás előállításukra, és gyógyszerkénti alkalmazásuk
JP4573925B2 (ja)	2010-11-04	新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
AP997A (en)	2001-08-09	Novel erythromycin derivatives, method for preparing them and their use as medicine.
JP5188520B2 (ja)	2013-04-24	新規なエリスロマイシン誘導体、製造方法及び医薬としての利用
JP2000514817A (ja)	2000-11-07	エリスロマイシンの新規な誘導体、それらの製造法及びそれらの薬剤としての使用
JP4864184B2 (ja)	2012-02-01	５−デスオサミニルエリスロノリドａの新規の２−ハロゲン化誘導体、それらの製造方法及び薬剤としてのそれらの使用
USRE38520E1 (en)	2004-05-18	Erythromycin derivatives, method for preparing same, and use thereof as drugs
AU761551B2 (en)	2003-06-05	Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines
MXPA99005226A (es)	2000-01-01	Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos
MXPA99005840A (es)	2000-04-24	Derivados novedosos de eritromicina, metodo de preparacion y aplicacion como medicamentos